Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

A recent breakthrough in medical research offers exciting possibilities for people dealing with diabetes and obesity. This ...

Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / ...

Obesity medications could help heavy drinkers cut down on the booze as well as helping them lose weight, new research has ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Alcohol intake dropped from 23 units to eight per week - roughly the equivalent to going from 12 pints a week to only four.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

However, a third drug also FDA-approved for weight loss, liraglutide (Saxenda), didn’t work as well as the others, ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...